Clearmind Medicine Inc. (CMND)
Clearmind Medicine Statistics
Share Statistics
Clearmind Medicine has 4.38M shares outstanding. The number of shares has increased by 38.29% in one year.
| Shares Outstanding | 4.38M |
| Shares Change (YoY) | 38.29% |
| Shares Change (QoQ) | 8.06% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 4.12M |
| Failed to Deliver (FTD) Shares | 6.23K |
| FTD / Avg. Volume | 0.58% |
Short Selling Information
The latest short interest is 620.7K, so 14.16% of the outstanding shares have been sold short.
| Short Interest | 620.7K |
| Short % of Shares Out | 14.16% |
| Short % of Float | 15.06% |
| Short Ratio (days to cover) | 0.23 |
Valuation Ratios
The PE ratio is -1.13 and the forward PE ratio is null. Clearmind Medicine's PEG ratio is 0.01.
| PE Ratio | -1.13 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 1.91 |
| P/FCF Ratio | -1.22 |
| PEG Ratio | 0.01 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Clearmind Medicine Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.72, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.72 |
| Quick Ratio | 1.72 |
| Debt / Equity | 0.02 |
| Total Debt / Capitalization | 1.68 |
| Cash Flow / Debt | -91.43 |
| Interest Coverage | -174.23 |
Financial Efficiency
Return on equity (ROE) is -1.69% and return on capital (ROIC) is -214.78%.
| Return on Equity (ROE) | -1.69% |
| Return on Assets (ROA) | -0.72% |
| Return on Capital (ROIC) | -214.78% |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1,313,669.5 |
| Employee Count | 4 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 377.97K |
| Effective Tax Rate | -0.08 |
Stock Price Statistics
The stock price has increased by -21.48% in the last 52 weeks. The beta is -1.46, so Clearmind Medicine's price volatility has been lower than the market average.
| Beta | -1.46 |
| 52-Week Price Change | -21.48% |
| 50-Day Moving Average | 1.39 |
| 200-Day Moving Average | 1.37 |
| Relative Strength Index (RSI) | 33.8 |
| Average Volume (20 Days) | 1.06M |
Income Statement
| Revenue | n/a |
| Gross Profit | -26.7K |
| Operating Income | -6.3M |
| Net Income | -5.25M |
| EBITDA | -5.85M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -1.7 |
Balance Sheet
The company has 6.57M in cash and 53.14K in debt, giving a net cash position of 6.52M.
| Cash & Cash Equivalents | 6.57M |
| Total Debt | 53.14K |
| Net Cash | 6.52M |
| Retained Earnings | -24.02M |
| Total Assets | 7.26M |
| Working Capital | 2.96M |
Cash Flow
In the last 12 months, operating cash flow was -4.86M and capital expenditures 0, giving a free cash flow of -4.86M.
| Operating Cash Flow | -4.86M |
| Capital Expenditures | 0 |
| Free Cash Flow | -4.86M |
| FCF Per Share | -1.14 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CMND does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -145.3% |
| FCF Yield | -94.5% |
Analyst Forecast
Currently there are no analyst rating for CMND.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Nov 28, 2023. It was a backward split with a ratio of 1:30.
| Last Split Date | Nov 28, 2023 |
| Split Type | backward |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | -6.03 |
| Piotroski F-Score | 2 |